Brief: Guerbet Receives EMA Acceptance Of Elucirem As The Brand Name For Gadopiclenol

Guerbet SA

13/06/2022 07:35

June 13 (Reuters) - Guerbet SA  GRBT.PA :
    * GUERBET RECEIVES EMA ACCEPTANCE OF ELUCIREMTM AS THE BRAND
NAME
FOR GADOPICLENOL
    * NO REGULATORY AUTHORITY HAS EVALUATED CLINICAL STUDY DATA
FOR
THIS PRODUCT TO DATE
    * GADOPICLENOL IS AN INVESTIGATIONAL MACROCYCLIC
GADOLINIUM-BASED
CONTRAST AGENT

Source text for Eikon:  ID:nGNE3000TM 
Further company coverage:  GRBT.PA 

 (Gdansk Newsroom)
 ((gdansk.newsroom@thomsonreuters.com; +48 58 769 66 00;))